Unlock stock picks and a broker-level newsfeed that powers Wall Street.

São Paulo - Delayed Quote BRL

Dimed S.A. Distribuidora de Medicamentos (PNVL3.SA)

8.71
-0.06
(-0.68%)
At close: April 23 at 5:07:31 PM GMT-3
Currency in BRL All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,942,462
4,942,462
4,461,017
3,990,475
3,225,408
Cost of Revenue
3,371,196
3,371,196
3,083,809
2,747,937
2,236,809
Gross Profit
1,571,266
1,571,266
1,377,208
1,242,538
988,599
Operating Expense
1,372,325
1,372,325
1,208,770
1,103,301
885,645
Operating Income
198,941
198,941
168,438
139,237
102,954
Net Non Operating Interest Income Expense
-110,125
-110,125
-104,045
-74,566
-27,969
Pretax Income
112,564
112,564
91,584
78,430
83,239
Tax Provision
7,055
7,055
-1,321
-7,915
3,813
Net Income Common Stockholders
105,509
105,509
92,905
86,345
79,426
Diluted NI Available to Com Stockholders
105,509
105,509
92,905
86,345
79,426
Basic EPS
0.71
0.71
0.62
0.58
0.53
Diluted EPS
0.70
0.70
0.62
0.58
0.53
Basic Average Shares
149,114.34
149,114.34
148,707.74
148,574.61
149,591.03
Diluted Average Shares
149,114.34
149,114.34
148,707.74
148,574.61
149,591.03
Total Operating Income as Reported
195,279
195,279
166,573
137,285
--
Rent Expense Supplemental
47,260
47,260
40,174
34,279
29,630
Total Expenses
4,743,521
4,743,521
4,292,579
3,851,238
3,122,454
Net Income from Continuing & Discontinued Operation
105,509
105,509
92,905
86,345
79,426
Normalized Income
86,669.71
86,669.71
93,712.84
88,204.13
80,623.27
Interest Income
6,181
6,181
5,713
2,682
7,247
Interest Expense
104,880
104,880
102,573
70,025
37,124
Net Interest Income
-110,125
-110,125
-104,045
-74,566
-27,969
EBIT
217,444
217,444
194,157
148,455
120,363
EBITDA
427,647
427,647
394,311
333,023
278,137
Reconciled Cost of Revenue
3,371,196
3,371,196
3,083,809
2,747,937
2,236,809
Reconciled Depreciation
210,203
210,203
200,154
184,568
157,774
Net Income from Continuing Operation Net Minority Interest
105,509
105,509
92,905
86,345
79,426
Total Unusual Items Excluding Goodwill
20,099
20,099
-1,224
-2,068
-1,255
Total Unusual Items
20,099
20,099
-1,224
-2,068
-1,255
Normalized EBITDA
407,548
407,548
395,535
335,091
279,392
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,259.71
1,259.71
-416.16
-208.87
-57.73
12/31/2021 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

D4S.MU Daiichi Sankyo Co Ltd
20.55
+1.73%
 
AMGN.MX Amgen Inc.
5,500.00
0.00%
 
4AB.F AbbVie Inc.
155.80
+0.65%
 
OPHLY Ono Pharmaceutical Co., Ltd.
4.1500
+5.87%
 
PFIZ34.SA Pfizer Inc.
31.80
-0.78%
 
ORNBVh.XC
 
NOV.MU Novo Nordisk A/S
54.09
-0.64%
 
GRF-P.MC Grifols SA
6.35
-0.78%
 
0R34.IL Johnson & Johnson
155.78
-1.34%
 
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,916.75
+2.31%